@article{3a29edf2e7df4448984e510e8d8a46b3,
title = "尿路上皮癌に対するエンホルツマブベドチン療法後に発生した骨髄異形成症候群(Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma)",
keywords = "*骨髄異形成症候群(化学的誘発,診断,薬物療法), *移行上皮癌(薬物療法,転移性), 骨髄検査, X線CT, *尿管腫瘍(薬物療法), *膀胱腫瘍(薬物療法), 致死的転帰, 細胞遺伝学的分析, 肺炎-間質性(化学的誘発,薬物療法), Eltrombopag(治療的利用), *Enfortumab Vedotin(治療的利用,毒性・副作用), 胸部CT, ヒト, 高齢者(65～79), 男",
author = "Yanagida Kazuki and Kawai Taketo and Seito Toyoshi and Matsumoto Kensuke and Kaneko Tomoyuki and Nakagawa Tohru",
year = "2024",
month = jul,
doi = "10.1002/iju5.12734",
language = "American English",
volume = "7",
pages = "316--319",
journal = "IJU Case Reports",
issn = "2577-171X",
publisher = "John Wiley and Sons Inc",
number = "4",
}
